P

Inventor

SIT SING-YUEN

US58 patents
⚠️ This page may combine multiple inventors who share the name “SIT SING-YUEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

29 patents
US7449479B2Nov 11, 2008

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO67 citations99
US6995174B2Feb 7, 2006

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO194 citations98
US7915291B2Mar 29, 2011

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO40 citations96
US6001836ADec 14, 1999

Dihydropyridine NPY antagonists: cyanoguanidine derivatives

BRISTOL MYERS SQUIBB CO98 citations95
US6562846B2May 13, 2003

Bisarylimidazolyl fatty acid amide hydrolase inhibitors

BRISTOL MYERS SQUIBB CO17 citations93
US5922735AJul 13, 1999

4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators

BRISTOL MYERS SQUIBB CO22 citations93
US5892045AApr 6, 1999

4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators

BRISTOL MYERS SQUIBB CO19 citations93
US8710229B2Apr 29, 2014

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO10 citations92
US9227940B2Jan 5, 2016

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO3 citations84
US8906889B2Dec 9, 2014

C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity

BRISTOL MYERS SQUIBB CO12 citations84
US7772180B2Aug 10, 2010

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO17 citations84
US6444675B2Sep 3, 2002

4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists

BRISTOL MYERS SQUIBB CO14 citations84
US6432960B2Aug 13, 2002

Squarate derivatives of dihydropyridine NPY antagonists

BRISTOL MYERS SQUIBB CO15 citations84
US10913738B2Feb 9, 2021

Aminotriazolopyridines as kinase inhibitors

BRISTOL MYERS SQUIBB CO7 citations83
US8889871B2Nov 18, 2014

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO3 citations74
US6391881B2May 21, 2002

Thiourea derivatives of dihydropyridine NPY antagonists

BRISTOL MYERS SQUIBB CO13 citations74
US6949574B2Sep 27, 2005

(Oxime)carbamoyl fatty acid amide hydrolase inhibitors

BRISTOL MYERS SQUIBB CO9 citations73
US6177429B1Jan 23, 2001

Dihydropyrazine derivatives as NPY antagonists

BRISTOL MYERS SQUIBB CO7 citations73
US9636375B2May 2, 2017

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO1 citations63
US7049309B2May 23, 2006

3-Thia-4-arylquinolin-2-one potassium channel modulators

BRISTOL MYERS SQUIBB CO3 citations63
US12157733B2Dec 3, 2024

Aminotriazolopyridines as kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations62
US6479482B2Nov 12, 2002

Alkylamine derivatives of dihydropyridine NPY antagonists

BRISTOL MYERS SQUIBB CO2 citations62
US5321046AJun 14, 1994

Hypocholesterolemic unsymmetrical dithiol ketals

BRISTOL MYERS SQUIBB CO2 citations57
US12275721B2Apr 15, 2025

Indazole carboxamides as kinase inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US12172975B2Dec 24, 2024

1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)

BRISTOL MYERS SQUIBB CO0 citations52
US8889854B2Nov 18, 2014

C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity

BRISTOL MYERS SQUIBB CO1 citations52
USRE39634EMay 15, 2007

Bisarylimidazoly fatty acid amide hydrolase inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US7179920B2Feb 20, 2007

3-thia-4-arylquinolin-2-one derivatives

BRISTOL MYERS SQUIBB CO0 citations52
US7151180B2Dec 19, 2006

Potassium channel modulators

BRISTOL MYERS SQUIBB CO0 citations52

BRISTOL MYERS CO

10 patents

REGUEIRO-REN ALICIA

4 patents

VIIV HEALTHCARE UK NO 5 LTD

3 patents

WANG ALAN XIANGDONG

1 patent

VIIV HEALTHCARE UK (NO 4) LTD

1 patent

VIIV HEALTHCARE UK NO 4 LTD

1 patent

PURDUE RESEARCH FOUNDATION

1 patent

Showing the top 50 of 58 patents by PatentIndex Score.